Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate® analyser.
about
Development of a concept for a personalized approach in the perioperative antiplatelet therapy administration/discontinuation management based on multiple electrode aggregometry in patients undergoing coronary artery surgery.Effect of preanalytical time-delay on platelet function as measured by multiplate, PFA-100 and VerifyNow.Rapid evaluation of platelet function using the Multiplate® Analyzer.Contemporary antiplatelet therapy in acute coronary syndromes: are there differences in outcomes and discontinuation between clopidogrel and ticagrelor?Prevalence and significance of CYP2C19*2 and CYP2C19*17 alleles in a New Zealand acute coronary syndrome population.Time dependent reduction in platelet aggregation using the multiplate analyser and hirudin blood due to platelet clumping.Tailored antiplatelet therapy to improve prognosis in patients exhibiting clopidogrel low-response prior to percutaneous coronary intervention for stable angina or non-ST elevation acute coronary syndrome.Preoperative hemostatic testing and the risk of postoperative bleeding in coronary artery bypass surgery patients.Desmopressin in vitro effects on platelet function, monitored with Multiplate, ROTEM and Sonoclot.Assessing the influence of diurnal variations and selective Xa inhibition on whole blood aggregometry.Thrombelastographic hypercoagulability and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): a randomized controlled trial.Prasugrel or double-dose clopidogrel to overcome clopidogrel low-response--the TAILOR (Thrombocytes And IndividuaLization of ORal antiplatelet therapy in percutaneous coronary intervention) randomized trial.
P2860
Q38542821-376A1B67-12D7-4A28-A71B-F4651A711D48Q39962890-83796DD2-EC60-4B0C-98DF-CF00652055C0Q44398909-21DF5EDC-0D8A-4914-A484-6857CD914592Q47258097-56E31B16-AC62-470A-983E-3F698EB13092Q47763354-2E8F0C92-BC9A-4C1F-86EB-E18C8B4F3B33Q49375827-9BB56CA3-B7CD-4BE9-A29C-D60FEA94A8F8Q51059922-D9A3CE02-1061-4E2B-8CFE-ED373D6B2F09Q51625232-899846B6-4260-41C0-A4DA-BDEC6F222DBEQ53164239-A6513740-2388-482F-B653-905C5A223414Q53437152-E71E2733-1CE3-41EA-9A75-8ED49B807A52Q53450451-75CCDBF4-217F-427D-8674-2049ED7D0F4FQ54580380-E977CB5F-6E00-45E0-A8A5-F11966D02EE4
P2860
Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate® analyser.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Methodological considerations ...... sing the Multiplate® analyser.
@en
Methodological considerations ...... sing the Multiplate® analyser.
@nl
type
label
Methodological considerations ...... sing the Multiplate® analyser.
@en
Methodological considerations ...... sing the Multiplate® analyser.
@nl
prefLabel
Methodological considerations ...... sing the Multiplate® analyser.
@en
Methodological considerations ...... sing the Multiplate® analyser.
@nl
P2093
P2860
P1433
P1476
Methodological considerations ...... sing the Multiplate® analyser.
@en
P2093
Anne C La Flamme
Lisa R Johnston
Peter D Larsen
Scott A Harding
P2860
P304
P356
10.3109/09537104.2012.694086
P577
2012-06-11T00:00:00Z